Malaria Vaccine 'could be widespread by 2015'

No Image

The world's first malaria vaccine could be in widespread use within two years following "significant" results from an ongoing clinical trial.

Researchers reported at a malaria conference in Durban, South Africa, that the jab continues to protect a substantial proportion of babies and young children 18 months after vaccination. The mosquito-borne disease kills around 660,000 people every year, most of them children in Sub-Saharan Africa.

British pharmaceutical firm GlaxoSmithKline (GSK), which makes the vaccine, said it would apply for a licence from the European Medicines Agency next year.

Editor's Comment
Your vote matters

This period, running from May 20 to 31 2024, is crucial for those who have not yet registered to vote. This announcement comes in response to a significant shortfall in registered voters following the recent registration period. As it stands, only 62% of the target number of voters registered, leaving a considerable gap.With Botswana's general elections scheduled for October, every eligible citizen needs to register and exercise their...

Have a Story? Send Us a tip
arrow up